Articles

Qiming Venture Partners Portfolio Companies YanYin Technology and ZhuanMa Bio Launch China's First CRISPR Gene Design Tool

Qiming Venture Partners Portfolio Companies YanYin Technology and ZhuanMa Bio Launch China's First CRISPR Gene Design Tool

The two parties will jointly develop a next-generation CRISPR design application platform, deeply integrating Zuanma Biotech's cutting-edge gene editing technology with YanYin AI's cloud-based R&D platform. This collaboration will deliver unprecedented convenience, precision, and efficiency to CRISPR gene editing users worldwide, dramatically streamlining the design and analysis workflows for gene editing experiments.

Unity Ventures Wins Multiple Awards Including 36Kr 2025 China Top 10 Early-Stage Investment Firms and China Top 10 Most Influential Early-Stage Investment Firms | Unity Honors

Unity Ventures Wins Multiple Awards Including 36Kr 2025 China Top 10 Early-Stage Investment Firms and China Top 10 Most Influential Early-Stage Investment Firms | Unity Honors

The more turbulent the technology itself becomes, the more you should invest in companies capable of achieving technological breakthroughs.